Position in MDXG
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$288,750
-$409,250 QoQ
Shares Held
75,000
-25.0% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#84
of 226 holders
Holding Since
Mar 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDXG Over Time
Shares Held
Position Value (USD)
Derivatives in MDXG
reported options exposure · as of Sep 30, 2025CallValue
$760,820
CallShares
109,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026DLD Asset Management, LP holds $1,239,620 across 7 Biotechnology names. MDXG ranks #1 (23.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDXG |
Mimedx Group, Inc.
This page
|
75,000 | $288,750 | |
| 2 | INSM |
INSMED Inc
|
2,500 | $266,550 | |
| 3 | ACAD |
Acadia Pharmaceuticals Inc
|
10,000 | $253,000 | |
| 4 | IRON |
Disc Medicine, Inc.
|
3,000 | $219,420 | |
| 5 | ANNX |
Annexon, Inc.
|
15,000 | $85,650 | |
| 6 | VYGR |
Voyager Therapeutics, Inc.
|
20,000 | $70,000 | |
| 7 | CTMX |
CytomX Therapeutics, Inc.
|
15,000 | $56,250 |
All Filings in MDXG
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $288,750 | 75,000 | Shares | Sole | 2026-08-13 | |
| 2025-09-30 | $698,000 | 100,000 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $760,820 | 109,000 | Call | Sole | 2025-11-14 | |
| 2025-03-31 | $836,000 | 110,000 | Call | Sole | 2025-05-29 | |
| 2025-03-31 | $608,000 | 80,000 | Put | Sole | 2025-05-29 | |
| No filing history on record for this holder in this stock. | ||||||